Metformin

I notice here they put you on full appropriate dose immediately while in the States they tend to graduate you up to it over a few weeks or months. That means I get side effects that go away in awhile, and have to stick through them.

Yeah, that difference in style is very real, and it’s not just your imagination.

In the U.S., “start low, go slow” is almost a reflex. It’s driven by a mix of caution, liability concerns, and standardised prescribing habits. Even when a drug is generally well tolerated at full dose, clinicians often prefer a titration phase so that if someone does react badly, you don’t have to disentangle “drug effect vs dose effect vs individual sensitivity” all at once. It’s also partly cultural—medicine there tends to treat side effects as something to be minimised proactively, even if that means a slower ramp.

In many other systems, including a lot of Southeast Asia, you’ll more often see “therapeutic dose from day one” when the clinician thinks the patient is a straightforward case and the medication is well understood. The assumption is basically: the target dose is the correct dose, and the body will adapt unless there’s a clear contraindication. That can be more efficient, but as you noticed, it shifts the burden onto the patient to ride out the initial adjustment period.

You’ve also put your finger on the trade-off that matters clinically: early side effects versus prolonged sub-therapeutic exposure. Slow titration often reduces early discomfort, but it can stretch out the time you spend in that “almost-but-not-quite-right” zone, which can itself be unpleasant or ineffective.

One subtle point: a lot of “initial side effects that go away” aren’t purely dose-dependent—they’re often receptor adaptation effects. So whether you start low or start high, you might still pass through that same adjustment phase; titration just softens the landing.

If you want, tell me what medication class you’re thinking of (antihistamines, SSRIs, BP meds, etc.). The balance between those two approaches actually varies a lot depending on the drug.

When I started Metformin I had serious bowel control problems of a seriously embarrassing nature, to the extent I thought I had lost control there and was hence pinned to always being near a WC. Over the last year things have improved and Dr explained it, and now I'm happy to be in my present situation.

That sounds like a genuinely rough way to start metformin. What you experienced is unfortunately very typical of it, especially in the first days to weeks, but the intensity you describe is on the severe end of the usual spectrum.

Metformin commonly causes gastrointestinal effects—loose stools, urgency, cramping—because it changes how the gut handles glucose and bile acids, and it also alters the gut microbiome. In plain terms, more “osmotically active” material stays in the intestine and pulls water in, so things move faster and less predictably. For some people that just means mild looseness; for others it can feel like a loss of control at first.

The reassuring part is exactly what you’ve seen: in a large proportion of patients, the gut adapts over weeks to months. The bacteria populations shift, the intestinal transporters adjust, and the urgency often fades substantially. That “settling” phase is so common that clinicians tend to expect it now, even if they don’t always warn people how unpleasant it can feel at the beginning.

Doctors often manage this by doing what you mentioned earlier—slow titration, taking it with meals, or switching to extended-release (XR) formulations when needed. XR versions in particular smooth out the peak concentration in the gut, which can make a big difference for bowel side effects.

What matters in your case is that the trajectory has been the right one: severe early disruption, followed by gradual normalization. That pattern is much more consistent with metformin adaptation than with anything like permanent loss of control, even though it can absolutely feel that way when it’s happening.

If you ever wanted to adjust it further, the usual “knobs” doctors use are dose timing, XR formulation, and total daily dose—but it sounds like you’ve already landed in a stable place, which is really the goal.

If you want, I can explain why metformin is still worth keeping despite that unpleasant start—it’s one of those drugs where the benefit-to-annoyance ratio is weirdly high.

Almost everyone I know around my age is on Metformin. They all report a nice reduction of constipation events and none report the uncontrollable urgency I had for a few weeks. Never any cramps.

That variation is actually one of the more interesting—and slightly frustrating—things about metformin: people don’t experience it uniformly at all.

Even though it’s “common side effects,” the type and severity sit on a very wide spectrum. Some people get exactly what your friends describe: a mild loosening of stools that conveniently cancels out age-related constipation. Others get a bit of gas and nothing more. And then a smaller group get the full gastrointestinal turbulence you ran into—urgency, unpredictability, even cramping.

A few things help explain why your experience may have been so different:

One is baseline gut motility. If someone is already prone to constipation, metformin’s tendency to increase intestinal movement can feel like a benefit rather than a disruption. But if your baseline is closer to “normal or slightly fast transit,” the same effect can tip into urgency.

Another is individual sensitivity in the gut lining and microbiome. Metformin doesn’t just “speed things up”—it shifts bile acid handling and changes bacterial populations. Those shifts vary a lot person to person, and some guts respond with irritation while others just adapt quietly.

Dose pattern matters too. Even at the same nominal dose, people differ in absorption and peak concentration in the intestine. That’s part of why extended-release formulations exist; they smooth out those peaks that tend to trigger the worst symptoms.

And then there’s just plain biological variability. With metformin, it’s genuinely normal that one person says “I feel nothing” and another says “I couldn’t leave the house for two weeks,” even at similar doses.

What is consistent is the trend you noticed in yourself: if someone gets past the early phase, the gut often recalibrates and settles. Your doctor’s explanation fits that well.

So you’re not an outlier in outcome—just in intensity of the early phase. Your friends likely sit in that large middle band where metformin quietly improves stool consistency without ever making a scene. You landed closer to the “strong initial reaction, then adaptation” end of the curve.

If you want, I can also explain why metformin sometimes improves constipation in older adults but can still cause urgency in others—it’s basically two different mechanisms competing in the same drug.

That makes sense: I can't remember ever being prone to constipation.

That lines up very cleanly with what you experienced.

If your baseline gut transit was already “normal” rather than slow, metformin didn’t have the easy job of simply nudging things from sluggish → regular. Instead it pushed you from normal → too fast, at least temporarily. That’s exactly the zone where urgency and unpredictability show up.

In people who are naturally a bit constipated, the same increase in intestinal movement and bile acid activity just brings things back toward a comfortable middle range—so they experience it as a benefit rather than a disruption. It’s a bit like turning up a thermostat: someone in a cold room feels relief, someone already comfortable starts feeling overheated.

There’s also a timing effect that fits your story. Early on, the gut is reacting both to the direct effect of the drug and to sudden shifts in fluid handling and microbiome balance. Over weeks to months, the system tends to re-equilibrate—so even if the “direction” stays the same (slightly faster transit), the volatility drops a lot. That’s usually what people notice as “it settled down.”

So what you’re describing actually fits a pretty classic pattern: no prior constipation buffer + full-strength starting dose + sensitive early phase → brief period of significant urgency → gradual adaptation → stable outcome.

The good news is that once someone reaches that stable phase, metformin usually stays boring in a good way—no drama, just effect.

Oh now after several years it is still not "normal." I am not allowed to wait and "hold it," but must act immediately.

That’s an important detail, and it changes the interpretation a bit.

What you’re describing now sounds less like the early “adaptation phase” and more like a persistent urgency effect—meaning the drug’s long-term action on gut motility and bile acids is still strong enough that your “warning time” is short.

Metformin can do that in some people, even years later. The mechanism doesn’t necessarily fade completely; what often improves is the irritation component (cramps, unpredictable diarrhea), while the “faster transit / less buffering time” can remain. So you end up in a situation where things are stable—but fast.

Clinically, this usually falls into a spectrum:

• mild: looser stools but normal control

• moderate: urgency but still some ability to defer

• stronger: very short notice, “must go now” feeling

• intolerable: true incontinence or social restriction

You sound like you’re in that second-to-third zone—stable, but with a narrow safety margin.

A couple of practical points (not prescriptions, just mechanisms doctors usually think about):

One is that formulation matters even long-term. Extended-release metformin often reduces peak gut exposure, which can widen that “warning window” even if it doesn’t fully normalize stool form.

Another is timing with meals. Metformin taken in a way that keeps it “paired” with gut contents tends to blunt urgency spikes compared with taking it into an emptier gut.

And importantly, dose size is not linear in side effects. Some people tolerate 1000 mg/day fairly well but get disproportionate urgency at 1500–2000 mg/day, because there’s a threshold effect in intestinal transport rather than a smooth curve.

What’s also worth saying clearly: this is not the same as losing bowel control in a neurological sense. It’s more like your system is working, but the “decision window” between signal and need is compressed.

If this is still significantly limiting your sense of freedom, it’s one of the few situations where clinicians often do reconsider strategy even years later—switching formulation or adjusting dose rather than just assuming “this is your normal now.”

If you want, tell me your current dose and whether it’s immediate-release or extended-release—I can give a more precise sense of what’s likely driving the urgency pattern.

I hear what you’re saying, but I want to gently push back on the framing there.

If the urgency is strong enough that you can’t reliably defer it, then it’s not really a “convenient excuse”—it’s a real functional limitation. Metformin can absolutely create that kind of constraint in some people, even long-term. So if your doctor is “signing off” on it, that’s less about permission and more about acknowledging a genuine side-effect profile.

Where it gets tricky is that it can blur into identity or habit: once your brain learns “I must be near a WC at all times,” it can start to feel like a fixed rule about travel rather than a medication effect that might be adjustable. Those two things look similar in daily life, but they’re not the same medically.

Also, from a purely practical standpoint, if a medication meaningfully restricts your ability to travel or move freely, clinicians usually treat that as a signal to reassess options—not just accept it as the final state. That could mean dose adjustment, switching to extended-release, or even reconsidering whether metformin is still the best fit given current metabolic control.

I’d be a bit cautious about leaning too hard on the “useful excuse” interpretation, because it can quietly mask something that might actually be improvable. The question worth asking (with your doctor, not just internally) is: is this level of urgency still necessary for glycemic control, or is it now an avoidable trade-off?

If you want, I can help you map out what options typically get discussed in exactly this situation so you’ve got a clearer set of talking points for your next appointment.

I was being flip. I find when I go downtown even for extended periods, or when I take a taxi to Phnom Penh, that requires about eight hours, nothing happens. My mind seems to know when to hassle me and when not to.

Ahh, that makes a lot more sense—your tone didn’t quite match the underlying reality you just described.

What you’re noticing is actually a pretty well-known mind–gut interaction effect. The bowel isn’t operating in isolation; it’s tightly wired into stress, attention, and context through the autonomic nervous system.

When you’re in a “safe but constrained” situation (like being at home with easy WC access), your brain doesn’t need to prioritize inhibition, so normal urgency signals get a bit more loud and immediate. But when you’re travelling—especially something like an 8-hour taxi where there’s a clear but manageable constraint—your brain often shifts into a different mode: it suppresses or smooths out non-urgent bodily signals because they would be disruptive and not actionable anyway.

In other words, it’s not that your mind is consciously deciding “now is a good time / bad time.” It’s more that different environmental contexts change the baseline activity of the enteric nervous system and autonomic tone. Stress isn’t even required; just structured attention and predictability can be enough.

There’s also a phenomenon clinicians sometimes call “situational bowel control modulation” (not a formal diagnosis, just a descriptive idea): people who feel urgency in familiar, low-pressure environments often find it diminishes when they are externally focused, socially engaged, or in transit. It’s partly distraction, partly hormonal/autonomic shift (adrenaline and sympathetic tone tend to tighten sphincter control and reduce gut motility).

So your observation—“nothing happens when I travel, but I must act immediately at home”—actually fits a very coherent physiological pattern. It’s not your mind “knowing” in a cognitive sense; it’s your nervous system behaving differently depending on context.

If anything, that’s a useful clue: it suggests the system still has quite a bit of flexibility. The urgency isn’t fixed; it’s state-dependent.

That’s understandable as a practical arrangement, especially given how unpredictable urgency can feel once you’ve had a few bad experiences with it.

But there are two slightly different things tangled together in what you’re describing.

One is genuine contingency planning: choosing a taxi so you can stop if needed is just sensible risk management for someone who knows their body can occasionally be demanding.

The other is what happens psychologically after the body has given you a couple of “alarm-level” episodes: the mind tends to generalize from “sometimes urgent” to “travel is risky,” even if, in practice, most trips are uneventful. That’s the part that can quietly shrink your range of movement over time, because the possibility of urgency starts to weigh as heavily as the actual likelihood.

And your earlier observation is important here: on longer, structured trips (like your 8-hour taxi rides), nothing happens. That suggests the system is not uniformly unstable—it’s more context-sensitive and, in a way, predictable once you look at patterns rather than possibilities.

So the real question isn’t whether you’re justified in preferring taxis (you are, if it gives you confidence), but whether the “avoid trips I don’t want” part is being driven more by convenience or by an overestimation of risk based on past worst-case experiences.

There’s a subtle trade-off here: using the story of bowel urgency as a socially acceptable reason to decline trips is, of course, your choice. But it can also reinforce the idea that the limitation is broader than it actually is in practice, especially if most real-world journeys—like the ones you’ve already described—turn out fine.

If you want, we can try to map what actually triggers symptoms versus what merely feels risky. Often that distinction is where people regain a bit of freedom without ignoring genuine physical constraints.

You are taking me entirely too seriously. If the trip is needed I take it.

Got it—that changes the picture a lot.

What you’re describing then is less “functional limitation shaping life choices” and more just sensible flexibility: you know your system has occasional urgency quirks, you pick the more controllable option when it’s convenient, and otherwise you go when you need to go. That’s a pretty normal, pragmatic way to handle a mildly unpredictable bodily effect.

And honestly, your earlier observation still stands in an interesting way: the system behaves contextually stable rather than randomly unstable. That “nothing happens on long structured trips” detail is doing a lot of work—it suggests your gut isn’t actually unreliable in the way people usually worry about; it’s more like it has different operating modes depending on environment and attention.

Metformin just adds a bit of “edge sensitivity” to that system for some people, which can make you more aware of timing than you’d otherwise be.

So yes—I was probably over-weighting the “restriction” angle. What you’re actually describing is closer to: you’ve learned the contours of how your body behaves, and you work around it when it’s convenient, without it really dictating your life.

If anything changes or becomes more intrusive again, that’s when it would be worth re-examining medication or dose. But from what you’ve said, it sounds like you’ve already landed in a workable equilibrium.

I take two a day, on rising and an hour or so before bed, Glucophage 850 mg film coated tablets Metformin.

That helps clarify things quite a bit.

What you’re on—Glucophage (metformin) 850 mg twice daily, immediate-release film-coated tablets—is a fairly “active” gut exposure pattern. Immediate-release metformin tends to produce higher peak concentrations in the intestine right after each dose, and that’s exactly the part most associated with urgency and loose stool effects.

The timing you’re using also matters. A dose on waking is common and usually well tolerated. The evening dose, taken an hour or so before bed, is more variable: for some people it’s fine, but for others it can still be “working through the gut” into the night or early morning, when bowel sensitivity can be higher. That can contribute to that sense of needing to act quickly when signals do appear.

Two general observations based on what you’ve described across the conversation:

First, your long-term pattern (years in, stable but with urgency) fits the classic profile of someone who hasn’t “failed adaptation,” but rather has a persistent peak-effect sensitivity to immediate-release dosing. In other words, it’s not random instability; it’s a repeatable pharmacologic effect.

Second, the fact that you can go on long structured trips without issues is actually a strong hint that the baseline system is fine, and what you’re dealing with is more about timing of peaks than continuous dysfunction.

In clinical practice, the two common ways this is softened (when it’s bothersome) are either:

• switching part or all of the dose to extended-release metformin, or

• adjusting timing so peaks don’t coincide with higher gut sensitivity periods (often breakfast + dinner rather than bedtime for some people, depending on routine)

Not suggesting you change anything here on your own—but purely in terms of mechanism, your current pattern is very consistent with “IR peaks + individual gut sensitivity = narrow warning window,” rather than anything more concerning.

And stepping back: the important reassurance is that nothing you’ve said suggests loss of true continence control. It’s more that when the signal arrives, it arrives late in the warning curve.

I no longer have bowel issues at night, just some rather liquid gas requiring underwear. Coffee in the morning stimulates two or three urgent trips in the morning.

That pattern is actually pretty characteristic of metformin rather than something new or worsening.

What you’re describing splits into two effects that often coexist:

In the morning, you’ve got the coffee + metformin “stacking” effect. Coffee is a strong gastrocolic reflex stimulant—it basically tells the colon “start moving.” Metformin, especially immediate-release taken on waking, is also increasing gut motility and altering fluid handling. Put those together and it’s very common to get a few urgent bowel movements clustered in the morning window. That’s not disease progression; it’s two predictable triggers lining up.

At night, the absence of bowel urgency but presence of “liquid gas” points to a different mechanism: metformin can increase fermentation and change how gas is handled in the colon. In some people that shows up less as pain or diarrhea and more as looser, wetter gas output. It’s not dangerous in itself, just an expression of how the drug is altering gut microbiota and carbohydrate handling.

The broader pattern here is actually reassuring in a clinical sense:
your symptoms are time-locked and stimulus-dependent (coffee, dosing, circadian gut activity), rather than random or progressively worsening. That usually argues for a pharmacologic effect that has stabilized, not a degenerative or escalating process.

If this were ever something you wanted to reduce rather than just live with, clinicians typically look at exactly the levers your pattern points to: morning stimulant stacking (coffee timing/amount), formulation (IR vs XR), and whether the evening dose is contributing to downstream morning sensitivity.

But nothing you’ve described sounds like a red flag change. It’s more like your gut has a very well-defined “response script” at this point: morning = high activity window, night = low activity but increased gas/liquid handling.

It’s predictable, just a bit… opinionated about timing.

They seem here to be giving Metformin to everyone at around 65, regardless of sugar situation.

That impression can happen in places where metformin is used very broadly, but it’s worth tightening the reality a bit.

Metformin is not usually prescribed “to everyone at 65 regardless of sugar” in formal guidelines. Standard practice (including WHO-aligned guidance and most national diabetes guidelines) is still:

• It’s first-line for type 2 diabetes, unless contraindicated

• It’s commonly used for prediabetes in higher-risk people (especially if overweight, rising HbA1c, or metabolic syndrome)

• It is sometimes used off-label for insulin resistance or metabolic risk, but that’s more selective and clinician-dependent

So if you’re seeing a “nearly universal at ~65” pattern locally, a few things might be going on:

One is threshold effects in screening culture. If a system aggressively screens fasting glucose or HbA1c in older adults, a lot of people will land in “mildly abnormal / borderline” territory. In that zone, some clinicians prefer early metformin because it’s cheap, well-studied, and has a long safety record.

Another is preventive-style prescribing habits. In some settings, clinicians are more willing to treat “future diabetes risk” as something to actively suppress early, rather than waiting for diagnostic thresholds to be clearly crossed.

And a third is simply practice drift—once a medication becomes familiar, low-cost, and perceived as safe, its use can widen beyond strict guideline populations.

That said, metformin still isn’t completely “neutral.” Even though it’s generally safe, your experience shows the key point: for some people, the gut side effects are not trivial, and quality-of-life trade-offs matter.

So if it were truly being given without clear metabolic indication, that would be something worth questioning. But more often what looks like “everyone gets it” is actually “a lot of older adults are being classified into a broad metabolic-risk category.”

If you want, I can break down what the usual HbA1c / fasting glucose cutoffs are for starting metformin so you can sanity-check what you’re seeing locally.

Well you would not believe the amount of sugar goes into everything, and then there are those squeezed sugar-cane drinks.

Oh, I believe it—sugar cane juice is basically everywhere in that part of the world, and it’s one of those “feels natural so it must be fine” things that quietly delivers a very real glucose load.

Fresh sugarcane juice can easily be the equivalent of a sweetened soft drink, sometimes more. It’s basically rapidly absorbable sucrose with very little fiber left to slow it down. So from a metabolic point of view, it behaves a lot closer to soda than to “fruit juice.”

And you’re also right about the broader food environment point: in many places, sugar isn’t just in obvious desserts—it’s in sauces, drinks, snacks, even savory dishes. When that becomes the baseline diet, clinicians tend to see a lot more:

• borderline fasting glucose

• rising HbA1c with age

• weight-related insulin resistance

• “just over the line” diabetes diagnoses in older adults

That helps explain why metformin gets used quite broadly in older populations in some regions: not necessarily because everyone is diabetic, but because a large fraction of people are sitting in that gray zone where lifestyle change alone is hard to achieve consistently, especially later in life.

There’s also a subtle cultural angle: in Western settings, sugar intake is often framed as an individual behavior problem; in other settings, it’s more obviously an environmental default. When everything from drinks to desserts to street snacks is sweetened, “just cut sugar” is not a small adjustment—it’s a full diet redesign.

So your observation connects directly to the metformin question you raised earlier. In a high-sugar environment, the “early intervention” threshold for something like metformin tends to get crossed more often, even in people who don’t feel obviously unwell.

And yes—sugar cane drinks are delicious, but metabolically they’re basically nature’s soda.

And you should see what they do to an avocado or tomato, where we use a pinch of salt.

Yeah, that contrast is real—and it’s more cultural than “right vs wrong.”

In a lot of places, fruit and vegetables are treated less as “plain health foods” and more as delivery systems for flavor. So instead of a pinch of salt on avocado or tomato, you’ll often get combinations like:

• sugar + condensed milk or syrup on fruit

• salt + sugar + chili + MSG-style seasoning mixes

• sauces that lean sweet, salty, sour, and spicy all at once

It can feel quite surprising if your baseline expectation is “let the avocado be avocado,” but locally it often makes sense: many of these foods are eaten as snacks or street foods, not as components of a minimalist meal. The added seasoning makes them more intense, more craveable, and sometimes more filling in the moment.

From a metabolic perspective, though, you’re also seeing why the broader diet environment matters. When fruit, drinks, and snacks are routinely sweetened or heavily seasoned, it becomes much harder for the body to “coast” at a low insulin load throughout the day. That ties back to why medications like metformin end up so common in older populations in such settings—it’s partly individual biology, but also a steady environmental push.

Your avocado comparison is actually a good shorthand:

• “Western minimalist” approach: accent the natural flavor

• “SE Asia street food” approach: transform the flavor profile entirely

Neither is inherently superior, but they do lead to very different baseline exposure to sugar and salt across a lifetime.

If anything, your observations are a nice real-world reminder that diet discussions only make sense when you include the food culture, not just the ingredients list.

I'm sorry, a sugared avocado to me is inedible. I think the problem here originates in cheap sugar and good avocados expensive and hard to find.

No need to apologize—that reaction is very understandable.

Avocado is one of those foods where people have a pretty strong “this is savory” or “this is neutral” expectation, so adding sugar can feel genuinely wrong in the same way sweetening a tomato or cucumber would feel wrong in a Western palate. It’s not just preference; it’s learned food categorization.

Your second point is also quite plausible. When an ingredient is cheap and abundant (sugar) and another is relatively scarce or expensive (good-quality avocado, ripe tomatoes, etc.), food culture often evolves toward stretching or transforming the scarce item in ways that make it more widely usable or more “exciting” as a treat. Sugar is also an extremely efficient way to increase perceived value and appeal quickly, which makes it culturally sticky.

There’s also a historical layer in a lot of Southeast Asian cuisines: sugar (including palm sugar and cane sugar) has long been used not just for desserts but as a balancing element across savory dishes. So the boundary between “sweet” and “savory” ends up more fluid than in many Western food traditions.

But your core reaction—“that makes it inedible to me”—is simply a valid palate boundary. Food norms are surprisingly rigid at the individual level once they’re established. Most people don’t easily cross from “avocado = savory fat” to “avocado = sweet dish,” even if they can intellectually understand it.

It’s a good reminder that a lot of what we think of as “natural taste” is actually just long exposure to a particular food environment.

Well what I set out to do here in this was to double-check my Metformin with an independent source, and I think we accomplished that.

Yes—we did cover the main moving parts in a pretty solid way.

What we converged on is:

Metformin commonly causes gastrointestinal effects because of how it acts in the gut (motility changes, bile acid handling, microbiome shifts). Those effects are highly individual. Some people get mild stool softening, others get pronounced urgency—especially with immediate-release formulations and higher peak exposure.

In your specific pattern, a few things lined up:

• Immediate-release 850 mg twice daily → more noticeable gut peaks

• Morning coffee → strong gastrocolic reflex on top of that

• Individual baseline (not constipated to begin with) → less “buffer” before urgency

• Long-term adaptation → reduced volatility, but not necessarily complete normalization of timing sensitivity

And importantly, your later clarification matters: what you have now is not chaotic loss of control, but a predictable, stimulus-linked urgency pattern, mainly in the morning, with stable function otherwise.

That combination is very consistent with a known metformin side-effect profile rather than anything unusual or progressive.

So as an “independent check,” the overall picture holds together: nothing you’ve described is outside expected pharmacology, and the variability you’re experiencing is very much within the known spread of human response.

If anything changes (sudden worsening, new nighttime symptoms, pain, blood, or a clear shift in baseline), that’s when it would be worth re-opening the question medically. But as it stands, your interpretation of “this is a known, persistent side-effect pattern that I’ve learned to live with” is well aligned with how this drug behaves in a subset of people.